Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

Canasa (Mesalamine) Suppositories For Active Ulcerative Proctitis Now Available In the US MONT SAINT-HILAIRE, QC -- April 18, 2001 -- Axcan Phama Inc. announced it has commenced marketing of Canasa 500 mg mesalamine (5-ASA) rectal suppositories in the United States. These suppositories, indicated for the treatment of active ulcerative proctitis, are marketed through Axcan's own specialized sales and marketing organization comprised of 77 field sales representatives in the United States. The total market for mesalamine suppositories was approximately US$22 million in fiscal 1999. "This is great news for patients suffering from active ulcerative proctitis since these suppositories could induce a rapid remission of their disease and an improved quality of life," commented Léon F. Gosselin, Axcan's President and CEO. "We are confident in our ability to serve a large portion of patients treated with mesalamine since this product fits perfectly into our gastroenterology expertise," he concluded. Since August 1999, at the request of the Food and Drug Administration, Axcan has been selling these suppositories in the United States under a temporary, emergency measure due to the lack of any other source of supply. Subsequently, Axcan successfully accelerated completion of preclinical and clinical studies and then filed an NDA on April 28, 2000, which review was expedited and led to approval on January 4, 2001. SOURCE: Axcan Pharma Inc. E-mail this page to a friend or colleague! To print, use this version